- Home
- IMRX vs HRTX Comparison
IMRX vs HRTX Comparison
Compare IMRX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- HRTX
- Stock Information
- Founded
- IMRX 2008
- HRTX 1983
- Country
- IMRX United States
- HRTX United States
- Employees
- IMRX N/A
- HRTX N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- IMRX Health Care
- HRTX Health Care
- Exchange
- IMRX Nasdaq
- HRTX Nasdaq
- Market Cap
- IMRX 232.9M
- HRTX 214.5M
- IPO Year
- IMRX 2021
- HRTX 1987
- Fundamental
- Price
- IMRX $6.87
- HRTX $1.16
- Analyst Decision
- IMRX Strong Buy
- HRTX Strong Buy
- Analyst Count
- IMRX 5
- HRTX 2
- Target Price
- IMRX $17.20
- HRTX $4.50
- AVG Volume (30 Days)
- IMRX 1.4M
- HRTX 1.5M
- Earning Date
- IMRX 11-10-2025
- HRTX 11-04-2025
- Dividend Yield
- IMRX N/A
- HRTX N/A
- EPS Growth
- IMRX N/A
- HRTX N/A
- EPS
- IMRX N/A
- HRTX N/A
- Revenue
- IMRX N/A
- HRTX $149,694,000.00
- Revenue This Year
- IMRX N/A
- HRTX $10.62
- Revenue Next Year
- IMRX N/A
- HRTX $12.99
- P/E Ratio
- IMRX N/A
- HRTX N/A
- Revenue Growth
- IMRX N/A
- HRTX 9.78
- 52 Week Low
- IMRX $1.10
- HRTX $1.04
- 52 Week High
- IMRX $10.08
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- IMRX 57.97
- HRTX 38.28
- Support Level
- IMRX $6.10
- HRTX $1.16
- Resistance Level
- IMRX $5.92
- HRTX $1.21
- Average True Range (ATR)
- IMRX 0.48
- HRTX 0.07
- MACD
- IMRX 0.09
- HRTX -0.01
- Stochastic Oscillator
- IMRX 90.11
- HRTX 8.33
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.